| William Shillinglaw, DO | |
|
509 Biltmore Ave, Asheville, NC 28801-4601 | |
| (828) 213-1995 | |
| (828) 213-1992 |
| Full Name | William Shillinglaw |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 37 Years |
| Location | 509 Biltmore Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093780009 | NPI | - | NPPES |
| 8912387 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 9901647 (North Carolina) | Secondary |
| 2086S0102X | Surgery - Surgical Critical Care | 9901647 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452482 PECOS PAC ID: 0648189969 Enrollment ID: O20040309000878 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Blue Ridge Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447261698 PECOS PAC ID: 0648181966 Enrollment ID: O20040729001574 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Mission Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114150190 PECOS PAC ID: 0749326106 Enrollment ID: O20100313000054 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532021 PECOS PAC ID: 0648189969 Enrollment ID: O20120316000506 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Shillinglaw, DO Po Box 602373, Charlotte, NC 28260-2373 Ph: (828) 250-2833 | William Shillinglaw, DO 509 Biltmore Ave, Asheville, NC 28801-4601 Ph: (828) 213-1995 |
News Archive
Antigenics Inc. reported today its results for the quarter ended June 30, 2010.
Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin. Appearing in the November 1 issue of Clinical Infectious Diseases and available online now, the article sounds a cautionary note as present day concerns about the novel H1N1 virus run high.
A recent study, currently available on the bioRxiv* preprint server, reveals that a specific region of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be targeted by antisense oligonucleotides to potently inhibit viral replication, and consequently the development of coronavirus disease (COVID-19).
› Verified 1 days ago
William Alan Bradshaw, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 14 Medical Park Dr, Asheville, NC 28803 Phone: 828-252-3366 Fax: 828-258-0891 | |
Darren P Bryant, MD Surgery Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Suite 4200, Asheville, NC 28801 Phone: 828-213-1995 | |
John P Henretta, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 Asheland Ave, Asheville, NC 28801 Phone: 828-213-9090 Fax: 828-213-9091 | |
Dr. Emma Goldsmith Rooney, MD Surgery Medicare: Medicare Enrolled Practice Location: 222 Asheland Ave, Asheville, NC 28801 Phone: 828-213-9090 | |
Michael J Schurr, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Suite 4200, Asheville, NC 28801 Phone: 828-213-1994 | |
Dr. Amir Ali Neshat, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 28 Ashley Rd, Asheville, NC 28805 Phone: 828-298-2014 |